INSIGHTS ON DRUG DEVELOPMENT

• How To Choose The Appropriate Filter Material For Every Sample

  Membrane compatibility plays a crucial role in reliable sample filtration. Knowing how different filter materials interact helps prevent common workflow issues and supports efficient filtration.

• Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis

  Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

• Simplify Cell Line Development

  Explore a streamlined method for isolating viable single cells using microfluidic dispensing and whole-well imaging that is designed to improve clonality, cell health, and reproducibility.

• The Complete Guide To Immunohistochemistry

  Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.

• Strategies For The Development Of Safe And Effective Pediatric Formulations

  5/12/2025

  Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.

• Calcium Carbonate Vs Titanium Dioxide: Why Particle Engineering Matter

  11/10/2025

  Discover how particle-engineered calcium carbonate offers a viable alternative to titanium dioxide in tablet coatings, achieving good opacity, process efficiency, and comparable tablet properties.

• The Next Generation Of Thermal Stability Testing For Biologic Drugs

  10/3/2024

  Achieving precise measurements in a high-throughput setting can be challenging without disrupting workflows or deadlines. Learn about a new tool for rapid biotherapeutic thermal stability characterization.

• Automating High-Throughput Screens Using Patient-Derived Organoids

  3/17/2025

  Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

• Nasal Delivery: Strategies For Success

  3/2/2026

  A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.